For the year ending 2025-12-31, MRK made $65,011M in revenue. $18,254M in net income. Net profit margin of 28.08%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 65,011 | 64,168 | 60,115 | 59,283 |
| Cost of sales | 16,382 | 15,193 | 16,126 | 17,411 |
| Selling, general and administrative | 10,733 | 10,816 | 10,504 | 10,042 |
| Research and development | 15,789 | 17,938 | 30,531 | 13,548 |
| Restructuring costs | 889 | 309 | 599 | 337 |
| Other (income) expense, net | -151 | 24 | -466 | -1,501 |
| Total costs, expenses and other | 43,944 | 44,232 | 58,226 | 42,839 |
| Income before taxes | 21,067 | 19,936 | 1,889 | 16,444 |
| Taxes on income | 2,804 | 2,803 | 1,512 | 1,918 |
| Net income from continuing operations | - | - | 377 | 14,526 |
| Less net income attributable to noncontrolling interests | - | - | 12 | 7 |
| Net income from continuing operations attributable to merck& co., inc | - | - | 365 | 14,519 |
| Net income | 18,263 | 17,133 | - | - |
| Income from discontinued operations, net of taxes and amounts attributable to noncontrolling interests | - | - | 0 | 0 |
| Less net income attributable to noncontrolling interests | 9 | 16 | - | - |
| Net income attributable to merck & co., inc | 18,254 | 17,117 | 365 | 14,519 |
| Basic EPS | 7.3 | 6.76 | 0.14 | 5.73 |
| Diluted EPS | 7.28 | 6.74 | 0.14 | 5.71 |
| Basic Average Shares | 2,502,000,000 | 2,532,000,000 | 2,537,000,000 | 2,532,000,000 |
| Diluted Average Shares | 2,507,000,000 | 2,541,000,000 | 2,547,000,000 | 2,542,000,000 |
Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK)